1 July 2019 in European Journal of Surgical Oncology
The oncological benefit of completion thyroidectomy (CT) following thyroid lobectomy (TL) is presumed to be similar to that of upfront total thyroidectomy(TT), from a patient's perspective the risk and inconvenience of further surgery adds significantly to the impact of the overall treatment. The aim of this study is to assess the impact of CT in terms of the duration of admission and associated complications. A study of consecutive patients with DTC identified from prospective MDT records of South-East Scotland from 2009 to 2015. Surgical data was extracted from electronic medical record. Of 361 patients diagnosed with DTC, 161 (45%) had CT. The median postoperative stay was 1 day (range 1-5days). In total 22 patients (14%)suffered complications. Four patients (3%) developed postoperative haematoma. Two (1%) had an identified permanent nerve palsy on the completion side. 13 patients (8%) remained on calcium supplementation for more than 6 months postoperatively and three patients (2%) developed wound complications. Our study confirms that CT is regularly performed (45%). Recent changes in international guidelines recognize increasing number of patients as eligible for a conservative approach but recommend CT based on whether upfront TT would have been recommended if the TL pathology were known from the outset. Such an approach fails to consider the additional risk and inconvenience of CT on the overall patient experience. Due to a relatively high rate of complications, only those patients who are most likely to benefit from further surgery to facilitate adjuvant radioactive iodine should be offered additional surgery.
4 July 2018 in Clinical Otolaryngology
1 December 2021 in The Surgeon
21 December 2020 in Clinical Otolaryngology
8 October 2026 in Clinical Otolaryngology
Objectives: To report early outcomes following implementation of a da Vinci Single‐Port transoral robotic surgery (SP‐TORS) programme in the United Kingdom. To provide contextual benchmarking, outcomes were compared with a historical institutional cohort treated using transoral laser microsurgery (TLM). Design: Retrospective institutional series with comparison against a historical cohort using stabilised inverse‐probability‐of‐treatment weighting. Setting: High‐volume UK Tertiary Head and Neck Centre. Participants: All patients undergoing SP‐TORS between April 2024 and September 2025. Comparative analyses were limited to oncological resections and included 33 SP‐TORS and 61 TLM cases. Main Outcome Measures: Feasibility, peri‐operative safety, postoperative haemorrhage, return to theatre, mortality, length of stay, time to oral diet, margin status and adjuvant therapy use. Results: Sixty‐six patients underwent SP‐TORS. All procedures were completed transorally without unplanned conversion or peri‐operative mortality. Postoperative haemorrhage occurred in 4.5%, with one return to theatre. Length of stay did not differ between groups. Time to oral diet was longer following SP‐TORS (adjusted ratio 1.51, p = 0.005). ASCO‐defined involved margins were similar (OR 0.30, 95% CI 0.06–1.56; p = 0.15), whereas specimen ink‐positive margins were less frequent following SP‐TORS (OR 0.31, 95% CI 0.11–0.91; p = 0.03). A sensitivity analysis using propensity‐matched T1/T2 pairs demonstrated a consistent directional effect, though this did not reach significance in the smaller matched cohort. Adjuvant therapy use was comparable. Conclusion: SP‐TORS implementation in a high‐volume UK centre was feasible and safe during early adoption, with low complication rates. Peri‐operative and early functional outcomes were broadly comparable with TLM. Although specimen ink‐positive margins were less frequent following SP‐TORS, interpretation should be cautious given the historical comparator and associated differences in departmental workflow. These findings support safe integration of SP‐TORS into transoral surgical practice and justify prospective evaluation.